Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00243
http://purl.obolibrary.org/obo/dinto_DB00243
|
|---|---|
| Preferred Name | ranolazine |
| Synonyms |
C24H33N3O4
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | ranolazine
|
|---|---|
| label | ranolazine
|
| DBSynonym |
(-)-ranolazine
ranolazine dihydrochloride
ranolazine 2hcl
|
| ATCCode | C01EB18
|
| Definition | Ranolazine is an antianginal medication. On January 31, 2006, ranolazine was approved for use in the United States by the FDA for the treatment of chronic angina. [Wikipedia]
|
| has effect |
See more
See less
|
| has pharmacological target | |
| inhibits | |
| type | |
| InChIKey | InChIKey=XKLMZUWKNUAPSZ-UHFFFAOYSA-N
|
| is metabolised by | |
| Synonym |
C24H33N3O4
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide
|
| xref |
National Drug Code Directory:61958-1001-1
RxList:http://www.rxlist.com/cgi/generic/ranexa.htm
ChemSpider:51354
PubChem Substance:46505145
PharmGKB:PA164746007
PubChem Compound:56959
Wikipedia:http://en.wikipedia.org/wiki/Ranolazine
Drugs.com:http://www.drugs.com/cdi/ranolazine.html
See more
See less
|
| CASRN | 142387-99-3
|
| prefixIRI | obo2:dinto_DB00243
|
| SMILES | COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)
|
| DBBrand | ranexa
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |